A new intracavitary ECG guiding method for real-time positioning the tip of peripheral inserted central catheters

A randomized open-labeled multicenter study to assess a new intracavitary ECG guiding method for real-time positioning the tip of three-way valve type peripheral inserted central catheters

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006183

Enrollment

Unknown

Registered

2015-03-29

Start date

2015-03-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncology

Interventions

Control :Method of surface prediction length

Test:New intracavitary ECG guiding method

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with malignant tumors who will require periodical infusion of chemotherapy drugs using three-valve PICC; 2. Aged >18 to <80 years old; 3. Baseline ECG records prior to PICC catheter showed normal P wave; 4. Agreed to participate in this study, and signed PICC informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with heart diseases, such as valvular heart disease, atrial fibrillation, supraventricular tachycardia, pulmonary heart disease or having a pacemaker and post cardiac surgery which may affect P waves. 2. Patients unable to lie in the prostrate or semi-supine position.

Design outcomes

Primary

Measure	Time frame
Single-time target rate;	—

Secondary

Measure	Time frame
Incidence of symptomatic thrombosis;Max p-wave amplitude;	—

Countries

China

Contacts

Public ContactYuan Ling; Li Rongmei; Xuwei

yuanling73@hotmail.com+86 13851517407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026